Year |
Citation |
Score |
2019 |
Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology. PMID 31888969 DOI: 10.1212/Wnl.0000000000008864 |
0.347 |
|
2019 |
Pettigrew C, Soldan A, Wang J, Wang M, Gottesman RF, Moghekar A, Albert MS. O3-09-05: VASCULAR RISK FACTORS AND CSF AD BIOMARKERS ARE INDEPENDENTLY ASSOCIATED WITH COGNITIVE DECLINE Alzheimer's & Dementia. 15: P906-P907. DOI: 10.1016/J.Jalz.2019.06.4676 |
0.326 |
|
2019 |
Soldan A, Pettigrew C, Zhu Y, Wang M, Gottesman RF, Albert MS. P4-447: COGNITIVE RESERVE MITIGATES THE IMPACT OF HYPERTENSION ON COGNITIVE TRAJECTORIES Alzheimer's & Dementia. 15: P1475-P1475. DOI: 10.1016/J.Jalz.2019.06.4119 |
0.306 |
|
2017 |
Soldan A, Pettigrew C, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiology of Aging. 60: 164-172. PMID 28968586 DOI: 10.1016/J.Neurobiolaging.2017.09.002 |
0.374 |
|
2017 |
Pettigrew C, Soldan A, Sloane K, Cai Q, Wang J, Wang MC, Moghekar A, Miller MI, Albert M. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease. Neuroimage. Clinical. 16: 439-446. PMID 28879085 DOI: 10.1016/J.Nicl.2017.08.022 |
0.315 |
|
2017 |
Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M. The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders. PMID 28394770 DOI: 10.1097/Wad.0000000000000194 |
0.33 |
|
2016 |
Pettigrew C, Soldan A, Zhu Y, Wang MC, Moghekar A, Brown T, Miller M, Albert M. Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage. Clinical. 12: 116-22. PMID 27408796 DOI: 10.1016/J.Nicl.2016.06.010 |
0.372 |
|
2016 |
Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O'Brien RJ, Selnes OA, Albert MS. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. Jama Neurology. PMID 27064267 DOI: 10.1001/Jamaneurol.2016.0194 |
0.349 |
|
2015 |
Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease. Human Brain Mapping. 36: 2826-41. PMID 25879865 DOI: 10.1002/Hbm.22810 |
0.345 |
|
2013 |
Pettigrew C, Soldan A, Li S, Lu Y, Wang MC, Selnes OA, Moghekar A, O'Brien R, Albert M, The Biocard Research Team. Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease. Cognitive Neuroscience. 4: 136-42. PMID 24168200 DOI: 10.1080/17588928.2013.831820 |
0.355 |
|
2013 |
Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O'Brien R. CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology. 81: 1753-8. PMID 24132375 DOI: 10.1212/01.Wnl.0000435558.98447.17 |
0.375 |
|
2013 |
Soldan A, Pettigrew C, Wang M, Li S, Lu Y, Albert M, Selnes O. O1-04-06: Relationship of cognitive reserve and APOE status to clinical symptom onset of mild cognitive impairment: The BIOCARD Cohort Alzheimer's & Dementia. 9: P134-P134. DOI: 10.1016/J.Jalz.2013.04.072 |
0.342 |
|
Show low-probability matches. |